General
Preferred name
IPIDACRINE
Synonyms
NIK?¡ì ()
1H-Cyclopenta[b]quinolin-9-amine, 2,3,5,6,7,8-hexahydro-, monohydrochloride ()
P&D ID
PD003184
CAS
62732-44-9
90043-86-0
Tags
natural product
drug
available
Drug Status
experimental
approved
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Ipidacrine is a reversible acetylcholinesterase (AChE) inhibitor for the treatment of cognitive disorders. (BOC Sciences Bioactive Compounds)
Compound Sets
14
BOC Sciences Bioactive Compounds
Cayman Chemical Bioactives
ChEMBL Drugs
Drug Repurposing Hub
DrugBank
DrugCentral
DrugCentral Approved Drugs
DrugMatrix
Enamine BioReference Compounds
MedChem Express Bioactive Compound Library
NIH Clinical Collections (NCC)
NPC Screening Collection
ReFrame library
TargetMol Bioactive Compound Library
External IDs
38
Properties
(calculated by RDKit )
Molecular Weight
188.13
Hydrogen Bond Acceptors
2
Hydrogen Bond Donors
1
Rotatable Bonds
0
Ring Count
3
Aromatic Ring Count
1
cLogP
2.03
TPSA
38.91
Fraction CSP3
0.58
Chiral centers
0.0
Largest ring
6.0
QED
0.68
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target
AChE
Cholinesterase (ChE)
MOA
Acetylcholinesterase inhibitor
Pathway
Neuronal Signaling
Source data